Putting Daubert In Proper Perspective

Law360, New York (August 1, 2013, 1:19 PM EDT) -- Recently, the federal circuits resolved a long-standing misconception about the rule regarding admissibility of expert testimony as set forth by Daubert v. Merrel Dow Pharm. Inc. 509 U.S. 579 (1993). Daubert determined, “‘General acceptance’ is not a necessary precondition to the admissibility of scientific evidence under the Federal Rules of Evidence.” The U.S. Supreme Court found that such a test would not allow for an expert to rely on evolving, novel scientific issues.

In Daubert, the petitioners alleged that a drug caused them to suffer significant...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.